Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/dinto_DB00111
http://purl.obolibrary.org/obo/dinto_DB00111
|
|---|---|
| Preferred Name | daclizumab |
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | daclizumab
|
|---|---|
| label | daclizumab
|
| DBSynonym |
anti-il-2
ig gamma-1 chain c region
humanized anticd25
|
| ATCCode | L04AC01
|
| Definition | Humanized IgG1 Mab that binds to the human interleukin-2 receptor (anti-Tac or anti-CD25). Daclizumab is a composite of human (90%) and murine (10%) antibody sequences. The human sequences were derived from the constant domains of human IgG1 and the variable framework regions of the Eu myeloma antibody. The murine sequences were derived from the complementarity-determining regions of a murine anti-Tac antibody.
|
| has pharmacological target | |
| type | |
| AHFScode | 92:00.00
|
| xref |
Wikipedia:http://en.wikipedia.org/wiki/Daclizumab
GenBank:J00228
Drugs Product Database (DPD):2241473
Drugs.com:http://www.drugs.com/cdi/daclizumab.html
PharmGKB:PA164764446
UniProtKB:P01857
RxList:http://www.rxlist.com/cgi/generic3/zenapax.htm
See more
See less
|
| CASRN | 152923-56-3
|
| prefixIRI | obo2:dinto_DB00111
|
| related with |
See more
See less
|
| may interact with | |
| DBBrand | zenapax (hoffmann-la roche inc)
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |